INTESTINAL FATE OF 5‐AMINOSALICYLIC ACID: REGIONAL AND SYSTEMIC KINETIC STUDIES IN RELATION TO INFLAMMATORY BOWEL DISEASE
Author:
Open Access
- 1 October 1997
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 81 (s2) , 1-30
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Salicylates for ulcerative colitis—their mode of actionPharmacology & Therapeutics, 1994
- Olsalazine in maintenance of clinical remission in patients with ulcerative colitisDigestive Diseases and Sciences, 1993
- Localization of Drug Release Sites from an Oral Sustained‐Release Formulation of 5‐ASA (Pentasa®) in the Gastrointestinal Tract Using Gamma ScintigraphyThe Journal of Clinical Pharmacology, 1993
- Prooxidant properties of 5-aminosalicylic acidDigestive Diseases and Sciences, 1992
- Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditionsEuropean Journal of Clinical Pharmacology, 1992
- Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel DiseaseDrug Safety, 1991
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditisDigestive Diseases and Sciences, 1987
- Where do all the tablets go in 1986?Gut, 1986
- Relative Systemic Availability of Sulfapyridine from Commercial Enteric‐Coated and Uncoated Sulfasalazine TabletsThe Journal of Clinical Pharmacology, 1979